Recent News

Connect with us

521 News Items found
Feature
Dr. Michael Overholtzer
17 Gerstner Sloan Kettering Students Will Graduate in 2023

Seventeen scientists are poised to receive their PhD degrees from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. Their years of dedication and training will be recognized on May 17, 2023, as part of Memorial Sloan Kettering’s 44th annual academic convocation.
A GSK student and faculty member discuss a research image displayed on a screen
Gerstner Sloan Kettering Graduate Students Receive 2022–2023 Fellowships

Every year, the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) awards fellowships to students who show promise in their scientific endeavors at GSK.
Paige Arnold working in a lab
2022 GSK Chairman’s Prize Celebrates Research That Sheds Light on Cellular Metabolic Processes

Paige Arnold, who will graduate from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) next spring, has been awarded the 2022 Chairman’s Prize. The competitive award is presented annually and was established by GSK’s Board of Trustees Chair Emeritus Louis V. Gerstner, Jr., for whom the school is named.
pancreatic surgeon and K12 alum Vinod Balachandran
MSK Program Prepares Clinicians for Careers in Translational Cancer Research

In the past 30 years, major strides have been made in translational medicine — the bridge that shepherds research findings from the lab to clinical practice. Researchers, physicians, and other specialists at Memorial Sloan Kettering Cancer Center (MSK) have played a major role in these successes, as they work together with the common goal of using their discoveries to create new treatments for people with cancer.
MSK pathologist Natasha Rekhtman and physician-scientist Charles Rudin
MSK Scientists Identify Rare (Rb-Proficient) Subtype of Small Cell Lung Cancer

Unlike most small cell lung cancer tumors, these retain a normal copy of a protein called RB.
Improved Scoring System for Myelodysplastic Syndromes Could Help Doctors Tailor Treatment

The revised scoring system incorporates molecular information related to 31 genes to help predict risk.
Side-by-side headshots of scientists Christopher Lima and Rhyan Puno
With Cryo-EM, SKI Scientists Determine Structure of Key Factor in RNA Quality Control

Called NEXT, the factor plays an important role in handing over RNA to the exosome for destruction.
MSK physician-scientist Yu Chen
MSK Scientists Identify New — and Very Common — Subtype of Prostate Cancer

The findings could pave the way toward more targeted treatments for the disease.
Event
GSK dean and graduates in their caps and gowns
MSK’s 2022 Convocation and Commencement Ceremony Recognizes Graduates and Award Winners

At Memorial Sloan Kettering Cancer Center’s 43rd annual event recognizing graduates and award winners, honorees were welcomed back to an in-person event.
MSK scientists Andrew Kung and Elli Papaemmanuil
New Type of Genetic Testing Aims To Benefit Children and Young Adults With Cancer

By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.